Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Akira Suda, Saki Hattori, Ikuko Kishida, Masatoshi Miyauchi, Yohko Shiraishi, Mami Fujibayashi, Natsuki Tsujita, Chie Ishii, Norio Ishii, Toshio Moritani & Yoshio Hirayasu. (2018) Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients. Neuropsychiatric Disease and Treatment 14, pages 2361-2366.
Read now
Read now
Articles from other publishers (85)
Davi C. Lagatta, Aline Fassini, Ana L. Terzian, Fernando M. A. Corrêa & Leonardo B. M. Resstel. (2023) The medial prefrontal cortex and the cardiac baroreflex activity: physiological and pathological implications. Pflügers Archiv - European Journal of Physiology 475:3, pages 291-307.
Crossref
Crossref
Laura Blok-Husum, Milka Ane Rank Brcelic, Hanin Kawa Farman Kawal Bassi, Svend Eggert Jensen, Rene Ernst Nielsen, Kristian Kragholm, Jesper Fleischer, Esben Laugesen & Christoffer Polcwiartek. (2023) Cardiovascular autonomic reflex tests using a handheld device in the diagnosis of cardiovascular autonomic neuropathy in patients with schizophrenia. American Heart Journal Plus: Cardiology Research and Practice 26, pages 100252.
Crossref
Crossref
Stephanie M. Liew, Enayet K. Chowdhury, Michael E. Ernst, Julia Gilmartin‐Thomas, Christopher M. Reid, Andrew Tonkin, Johannes Neumann, John J. McNeil & David M. Kaye. (2022) Prescribed opioid use is associated with adverse cardiovascular outcomes in community‐dwelling older persons. ESC Heart Failure 9:6, pages 3973-3984.
Crossref
Crossref
Xiaodong Wu, Lei Xia, Yating Yang, Ling Zhang, Mengdie Li, Tingfang Liu, Yuanli Liu, Robert O. Cotes, Feng Jiang, Yi-lang Tang & Huanzhong Liu. (2022) Mortality among psychiatric inpatients in China: A national survey. Asian Journal of Psychiatry 77, pages 103262.
Crossref
Crossref
Sheharyar Minhas, Jay R Patel, Maira Malik, David Hana, Fatima Hassan & Rami N. Khouzam. (2022) Mind-Body Connection: Cardiovascular Sequelae of Psychiatric Illness. Current Problems in Cardiology 47:10, pages 100959.
Crossref
Crossref
Talip E. Eroglu, Carlo A. Barcella, Marieke T. Blom, Patrick C. Souverein, Grimur H. Mohr, Christian Torp‐Pedersen, Fredrik Folke, Mads Wissenberg, Anthonius de Boer, Gunnar H. Gislason & Hanno L. Tan. (2021) Opioid use is associated with increased out‐of‐hospital cardiac arrest risk among 40 000‐cases across two countries. British Journal of Clinical Pharmacology 88:5, pages 2256-2266.
Crossref
Crossref
Rada R Veeneman, Jentien M Vermeulen, Abdel Abdellaoui, Eleanor Sanderson, Robyn E Wootton, Rafik Tadros, Connie R Bezzina, Damiaan Denys, Marcus R Munafò, Karin J H Verweij & Jorien L Treur. (2022) Exploring the Relationship Between Schizophrenia and Cardiovascular Disease: A Genetic Correlation and Multivariable Mendelian Randomization Study. Schizophrenia Bulletin 48:2, pages 463-473.
Crossref
Crossref
Maria S Neumeier, Stephanie Homan, Stefan Vetter, Erich Seifritz, John M Kane, Maximilian Huhn, Stefan Leucht & Philipp Homan. (2021) Examining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance. Schizophrenia Bulletin 47:6, pages 1601-1610.
Crossref
Crossref
Carlo Alberto Barcella, Grimur Mohr, Kristian Kragholm, Daniel Christensen, Thomas A Gerds, Christoffer Polcwiartek, Mads Wissenberg, Casper Bang, Fredrik Folke, Christian Torp-Pedersen, Lars Vedel Kessing, Gunnar Hilmar Gislason & Kathrine Bach Søndergaard. (2021) Risk of out-of-hospital cardiac arrest in patients with bipolar disorder or schizophrenia. Heart 107:19, pages 1544-1551.
Crossref
Crossref
Yu-Chi Kuo, Dan-Yan Chang & Yi-Hung Liao. (2021) Twelve-Weeks of Bench-Step Exercise Training Ameliorates Cardiopulmonary Fitness and Mood State in Patients with Schizophrenia: A Pilot Study. Medicina 57:2, pages 149.
Crossref
Crossref
Christoffer Polcwiartek, Brett D. Atwater, Kristian Kragholm, Daniel J. Friedman, Carlo A. Barcella, Rubina Attar, Claus Graff, Jonas B. Nielsen, Adrian Pietersen, Peter Søgaard, Christian Torp‐Pedersen & Svend E. Jensen. (2021) Association Between ECG Abnormalities and Fatal Cardiovascular Disease Among Patients With and Without Severe Mental Illness. Journal of the American Heart Association 10:2.
Crossref
Crossref
Ying Chun Tai, Shih-Hsien Lin, Kao Chin Chen, I Hui Lee, Po See Chen, Lan-Ting Lee, Hsin Chun Tsai, Tzung Lieh Yeh & Yen Kuang Yang. (2020) Heart Rate Variability with Deep Breathing in Drug-Naïve Patients with Schizophrenia. Applied Psychophysiology and Biofeedback 45:4, pages 275-282.
Crossref
Crossref
Anuj Rastogi, Dylan Viani-Walsh, Shareef Akbari, Nicholas Gall, Fiona Gaughran & John Lally. (2020) Pathogenesis and management of Brugada syndrome in schizophrenia: A scoping review. General Hospital Psychiatry 67, pages 83-91.
Crossref
Crossref
Monalisa Jena, Archana Mishra, Biswa Ranjan Mishra, Santanu Nath & Rituparna Maiti. (2020) Effect of lurasidone versus olanzapine on cardiometabolic parameters in unmedicated patients with schizophrenia: a randomized controlled trial. Psychopharmacology 237:11, pages 3471-3480.
Crossref
Crossref
Wei‐Chia Huang, Wei‐Shih Liu, Tzu‐ting Chen, Wen‐Hao Chen & Wei‐Lieh Huang. (2020) Parasympathetic activity as a potential biomarker of negative symptoms in patients with schizophrenia. Asia-Pacific Psychiatry 12:3.
Crossref
Crossref
Rachel M.A. ter Bekke & Paul G.A. Volders. (2020) Haloperidol and sudden death in first acute myocardial infarction. IJC Heart & Vasculature 26, pages 100482.
Crossref
Crossref
Daming Sun, Liliang Li, Xiang Zhang, Thomas G. Blanchard, David R. Fowler & Ling Li. (2019) Causes of Sudden Unexpected Death in Schizophrenia Patients. American Journal of Forensic Medicine & Pathology 40:4, pages 312-317.
Crossref
Crossref
Carlo Alberto Barcella, Grimur H. Mohr, Kristian Kragholm, Paul Blanche, Thomas A. Gerds, Mads Wissenberg, Steen M. Hansen, Kristian Bundgaard, Freddy K. Lippert, Fredrik Folke, Christian Torp-Pedersen, Lars V. Kessing, Gunnar H. Gislason & Kathrine B. Søndergaard. (2019) Out-of-hospital cardiac arrest in patients with psychiatric disorders — Characteristics and outcomes. Resuscitation 143, pages 180-188.
Crossref
Crossref
Arjen L. Sutterland, Marieke T. Blom, Katinka Ladee, Jorieke J.M. Lubbers, Dan Cohen, Lieuwe de Haan & Hanno L. Tan. (2019) Increased prevalence of ECG suspicious for Brugada Syndrome in recent onset schizophrenia spectrum disorders. Schizophrenia Research 210, pages 59-65.
Crossref
Crossref
Benito Morentin & Luis F. Callado. (2019) Sudden cardiac death associated to substances of abuse and psychotropic drugs consumed by young people: A population study based on forensic autopsies. Drug and Alcohol Dependence 201, pages 23-28.
Crossref
Crossref
Christoffer Polcwiartek, Kristian Kragholm, Steen M Hansen, Brett D Atwater, Daniel J Friedman, Carlo A Barcella, Claus Graff, Jonas B Nielsen, Adrian Pietersen, Jimmi Nielsen, Peter Søgaard, Christian Torp-Pedersen & Svend E Jensen. (2019) Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia. Schizophrenia Bulletin.
Crossref
Crossref
Mevhibe N. Tümüklü, Mustafa M. Tümüklü, Vladislav Nesterenko, Karu Jayathilake, Charles M. Beasley & Herbert Y. Meltzer. (2019) Twenty-Four–Hour Measures of Heart Rate–Corrected QT Interval, Peak-to-End of the T-Wave, and Peak-to-End of the T-Wave/Corrected QT Interval Ratio During Antipsychotic Treatment. Journal of Clinical Psychopharmacology 39:2, pages 100-107.
Crossref
Crossref
Angela Owusu–Ansah, Anto Berko Panyin, Christian Obirikorang, Christian Agyare, Emmanuel Acheampong, Simon Kwofie, Enoch Odame Anto & Emmanuella Nsenbah Batu. (2018) Metabolic Syndrome among Schizophrenic Patients: A Comparative Cross-Sectional Study in the Middle Belt of Ghana. Schizophrenia Research and Treatment 2018, pages 1-9.
Crossref
Crossref
Kevin J. Li, Aaron P. Greenstein & Lynn E. Delisi. (2018) Sudden death in schizophrenia. Current Opinion in Psychiatry 31:3, pages 169-175.
Crossref
Crossref
Saki Hattori, Ikuko Kishida, Akira Suda, Masatoshi Miyauchi, Yohko Shiraishi, Mami Fujibayashi, Natsuki Tsujita, Chie Ishii, Norio Ishii, Toshio Moritani, Masataka Taguri & Yoshio Hirayasu. (2018) Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia. Schizophrenia Research 193, pages 134-138.
Crossref
Crossref
Ary Gadelha, André Zugman, Mariana Bendlin Calzavara, Remo Holanda de Mendonça Furtado, Fulvio Alexandre Scorza & Rodrigo Afonsecca Bressan. (2018) Is adenosine associated with sudden death in schizophrenia? A new framework linking the adenosine pathway to risk of sudden death. Neuroscience & Biobehavioral Reviews 84, pages 29-34.
Crossref
Crossref
. 2017. ECG Time Series Variability Analysis. ECG Time Series Variability Analysis
13
74
.
Kathlyn J. Ronaldson. (2017) Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management. CNS Drugs 31:9, pages 777-795.
Crossref
Crossref
Lars Jakobsen, Christian J. Terkelsen, Evald H. Christiansen, Michael Maeng, Lisette O. Jensen, Karsten Veien, Bent Raungaard, Svend E. Jensen, Frank Mehnert & Søren P. Johnsen. (2017) Severe Mental Illness and Clinical Outcome After Primary Percutaneous Coronary Intervention. The American Journal of Cardiology 120:4, pages 550-555.
Crossref
Crossref
Andrew Harris. (2017) ‘Natural’ and ‘Unnatural’ medical deaths and coronial law: A UK and international review of the medical literature on natural and unnatural death and how it applies to medical death certification and reporting deaths to coroners. Medicine, Science and the Law 57:3, pages 105-114.
Crossref
Crossref
Lee Seng Esmond Seow, Siow Ann Chong, Peizhi Wang, Saleha Shafie, Hui Lin Ong & Mythily Subramaniam. (2017) Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care. Comprehensive Psychiatry 74, pages 196-203.
Crossref
Crossref
Nuria Berrocal-Izquierdo, Miquel Bioque & Miguel Bernardo. (2017) Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?. International Clinical Psychopharmacology 32:2, pages 80-86.
Crossref
Crossref
Ha Hyun BaeHai Joo YoonEun Kyung ParkJong Il Lee. (2017) The Effects on Metabolic Syndrome Parameters of Atypical Antipsychotic Agents in Schizophrenics Patients : 3 Years Retrospective Follow Up. Korean Journal of Schizophrenia Research 20:1, pages 5.
Crossref
Crossref
Daniel S. Quintana, Maja Elstad, Tobias Kaufmann, Christine L. Brandt, Beathe Haatveit, Marit Haram, Mari Nerhus, Lars T. Westlye & Ole A. Andreassen. (2016) Resting-state high-frequency heart rate variability is related to respiratory frequency in individuals with severe mental illness but not healthy controls. Scientific Reports 6:1.
Crossref
Crossref
Chung-Chih Hsu, Chih-Sung Liang, Yueh-Ming Tai & Shu-Li Cheng. (2016) Incongruent changes in heart rate variability and body weight after discontinuing aerobic exercise in patients with schizophrenia. International Journal of Psychophysiology 109, pages 132-137.
Crossref
Crossref
Donna Ames, Sian M. Carr-Lopez, Mary A. Gutierrez, Joseph M. Pierre, Jennifer A. Rosen, Susan Shakib & Lynn M. Yudofsky. (2016) Detecting and Managing Adverse Effects of Antipsychotic Medications. Psychiatric Clinics of North America 39:2, pages 275-311.
Crossref
Crossref
Lydia Krexi, Roxani Georgiou, Dimitra Krexi & Mary N Sheppard. (2015) Sudden cardiac death with stress and restraint: The association with sudden adult death syndrome, cardiomyopathy and coronary artery disease. Medicine, Science and the Law 56:2, pages 85-90.
Crossref
Crossref
Fulvio A. Scorza, Carla A. Scorza, Esper A. Cavalheiro, Sergio Tufik & Monica L. Andersen. (2016) Obstructive sleep apnea: Underestimated risk factor in sudden cardiac death in schizophrenia. Sleep Science 9:2, pages 57-58.
Crossref
Crossref
Chang-Chieh Wu, Fu-Ming Tsai, Mao-Liang Chen, Semon Wu, Ming-Cheng Lee, Tzung-Chieh Tsai, Lu-Kai Wang & Chun-Hua Wang. (2016)
Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y
1
and P2Y
12
Receptors
. BioMed Research International 2016, pages 1-12.
Crossref
Crossref
D. S. Quintana, L. T. Westlye, T. Kaufmann, Ø. G. Rustan, C. L. Brandt, B. Haatveit, N. E. Steen & O. A. Andreassen. (2016) Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls. Acta Psychiatrica Scandinavica 133:1, pages 44-52.
Crossref
Crossref
Dan Cohen. 2016. Life-Threatening Effects of Antipsychotic Drugs. Life-Threatening Effects of Antipsychotic Drugs
311
332
.
Steffen Schulz, Jens Haueisen, Karl-Jürgen Bär & Voss Andreas. (2015) High-resolution joint symbolic analysis to enhance classification of the cardiorespiratory system in patients with schizophrenia and their relatives. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 373:2034, pages 20140098.
Crossref
Crossref
Heikki V. Huikuri. (2015) Psychotropic Medications and the Risk of Sudden Cardiac Death. Journal of the American Heart Association 4:2.
Crossref
Crossref
Chi‐Shin Wu, Yu‐Ting Tsai & Hui‐Ju Tsai. (2015) Antipsychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation‐wide Case‐Crossover Study. Journal of the American Heart Association 4:2.
Crossref
Crossref
Joaquín S. Lucena, Pedro M. Garamendi, Gonzalo Guzzo-Merello & Pablo García-Pavía. 2015. Clinico-Pathological Atlas of Cardiovascular Diseases. Clinico-Pathological Atlas of Cardiovascular Diseases
299
316
.
Jun Wang, Yan-song Liu, Wen-xian Zhu, Fu-quan Zhang & Zhen-he Zhou. (2014) Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis. Scientific Reports 4:1.
Crossref
Crossref
Marco Herbsleb, Tobias Mühlhaus & Karl-Jürgen Bär. (2014) Differential Cardiac Effects of Aerobic Interval Training Versus Moderate Continuous Training in a Patient with Schizophrenia: A Case Report. Frontiers in Psychiatry 5.
Crossref
Crossref
A. Millier, U. Schmidt, M.C. Angermeyer, D. Chauhan, V. Murthy, M. Toumi & N. Cadi-Soussi. (2014) Humanistic burden in schizophrenia: A literature review. Journal of Psychiatric Research 54, pages 85-93.
Crossref
Crossref
Dan M. Roden. (2014) The Brugada ECG and Schizophrenia. Circulation: Arrhythmia and Electrophysiology 7:3, pages 365-367.
Crossref
Crossref
Marieke T. BlomDan CohenAdrie SeldenrijkBrenda W.J.H. PenninxGiel NijpelsCoen D.A. StehouwerJacqueline M. DekkerHanno L. Tan. (2014) Brugada Syndrome ECG Is Highly Prevalent in Schizophrenia. Circulation: Arrhythmia and Electrophysiology 7:3, pages 384-391.
Crossref
Crossref
Gernot ErnstGernot Ernst. 2014. Heart Rate Variability. Heart Rate Variability
269
288
.
Paola Giusti-Rodríguez & Patrick F. Sullivan. (2013) The genomics of schizophrenia: update and implications. Journal of Clinical Investigation 123:11, pages 4557-4563.
Crossref
Crossref
Joanna Sweeting, Johan Duflou & Christopher Semsarian. (2013) Postmortem analysis of cardiovascular deaths in schizophrenia: A 10-year review. Schizophrenia Research 150:2-3, pages 398-403.
Crossref
Crossref
Stephan Ripke, Colm O'Dushlaine, Kimberly Chambert, Jennifer L Moran, Anna K Kähler, Susanne Akterin, Sarah E Bergen, Ann L Collins, James J Crowley, Menachem Fromer, Yunjung Kim, Sang Hong Lee, Patrik K E Magnusson, Nick Sanchez, Eli A Stahl, Stephanie Williams, Naomi R Wray, Kai Xia, Francesco Bettella, Anders D Borglum, Brendan K Bulik-Sullivan, Paul Cormican, Nick Craddock, Christiaan de Leeuw, Naser Durmishi, Michael Gill, Vera Golimbet, Marian L Hamshere, Peter Holmans, David M Hougaard, Kenneth S Kendler, Kuang Lin, Derek W Morris, Ole Mors, Preben B Mortensen, Benjamin M Neale, Francis A O'Neill, Michael J Owen, Milica Pejovic Milovancevic, Danielle Posthuma, John Powell, Alexander L Richards, Brien P Riley, Douglas Ruderfer, Dan Rujescu, Engilbert Sigurdsson, Teimuraz Silagadze, August B Smit, Hreinn Stefansson, Stacy Steinberg, Jaana Suvisaari, Sarah Tosato, Matthijs Verhage, James T Walters, Elvira Bramon, Aiden P Corvin, Michael C O'Donovan, Kari Stefansson, Edward Scolnick, Shaun Purcell, Steven A McCarroll, Pamela Sklar, Christina M Hultman & Patrick F Sullivan. (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genetics 45:10, pages 1150-1159.
Crossref
Crossref
Marjo Kiviniemi, Jaana Suvisaari, Heli Koivumaa-Honkanen, Unto Häkkinen, Matti Isohanni & Helinä Hakko. (2013) Antipsychotics and mortality in first-onset schizophrenia: Prospective Finnish register study with 5-year follow-up. Schizophrenia Research 150:1, pages 274-280.
Crossref
Crossref
Lorenzo Burti, Loretta Berti, Elena Bonfioli & Irene Fiorini. 2013. Improving Mental Health Care. Improving Mental Health Care
114
130
.
Steffen Schulz, Nadine Tupaika, Sandy Berger, Jens Haueisen, Karl-Jürgen Bär & Andreas Voss. (2013) Cardiovascular coupling analysis with high-resolution joint symbolic dynamics in patients suffering from acute schizophrenia. Physiological Measurement 34:8, pages 883-901.
Crossref
Crossref
Jennifer L. Pilgrim & Olaf H. Drummer. (2013) The toxicology and comorbidities of fatal cases involving quetiapine. Forensic Science, Medicine, and Pathology 9:2, pages 170-176.
Crossref
Crossref
Sung Hak Lee, Hong Rye Kim, Rong Xun Han, Reza K. Oqani & Dong Il Jin. (2011) Cardiovascular risk assessment of atypical antipsychotic drugs in a zebrafish model. Journal of Applied Toxicology 33:6, pages 466-470.
Crossref
Crossref
Evangelos Papanastasiou. (2012) The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review. Therapeutic Advances in Psychopharmacology 3:1, pages 33-51.
Crossref
Crossref
Hugo D. Critchley & Neil A. Harrison. (2013) Visceral Influences on Brain and Behavior. Neuron 77:4, pages 624-638.
Crossref
Crossref
Miquel Bernardo, Miquel Bioque, Mara Parellada, Jerónimo Saiz Ruiz, Manuel J. Cuesta, Adrián Llerena, Julio Sanjuán, Josefina Castro-Fornieles, Celso Arango & Bibiana Cabrera. (2013) Assessing clinical and functional outcomes in a gene–environment interaction study in first episode of psychosis (PEPs). Revista de Psiquiatría y Salud Mental (English Edition) 6:1, pages 4-16.
Crossref
Crossref
Miquel Bernardo, Miquel Bioque, Mara Parellada, Jerónimo Saiz Ruiz, Manuel J. Cuesta, Adrián Llerena, Julio Sanjuán, Josefina Castro-Fornieles, Celso Arango & Bibiana Cabrera. (2013) Criterios de valoración clínicos y de funcionamiento en un estudio de interacción gen-ambiente en primeros episodios psicóticos (PEPs). Revista de Psiquiatría y Salud Mental 6:1, pages 4-16.
Crossref
Crossref
Hugo D. Critchley, Jessica Eccles & Sarah N. Garfinkel. 2013. Autonomic Nervous System. Autonomic Nervous System
59
77
.
Hassan Rahmoune, W. Harris, Paul C. Guest & Sabine Bahn. (2012) Explorando o componente inflamatório da esquizofrenia. Archives of Clinical Psychiatry (São Paulo) 40:1, pages 28-34.
Crossref
Crossref
V. P. Volkov. (2012) Sudden cardiac death and antipsychotic medications: literature review. Cardiovascular Therapy and Prevention 11:5, pages 79-82.
Crossref
Crossref
Markad Kamath, Mari Watanabe & Adrian UptonBrook Henry. 2012. Heart Rate Variability (HRV) Signal Analysis. Heart Rate Variability (HRV) Signal Analysis
443
468
.
Fulvio A. Scorza, Marly de Albuquerque, Ricardo M. Arida & Roberta Monterazzo Cysneiros. (2012) Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss?. Arquivos de Neuro-Psiquiatria 70:10, pages 814-816.
Crossref
Crossref
Evangelos Papanastasiou. (2012) Interventions for the metabolic syndrome in schizophrenia: a review. Therapeutic Advances in Endocrinology and Metabolism 3:5, pages 141-162.
Crossref
Crossref
Karl-Jürgen Bär, Tobias Rachow, Steffen Schulz, Katharina Bassarab, Stefanie Haufe, Sandy Berger, Kathrin Koch & Andreas Voss. (2012) The Phrenic Component of Acute Schizophrenia – A Name and Its Physiological Reality. PLoS ONE 7:3, pages e33459.
Crossref
Crossref
J. Honkola, E. Hookana, S. Malinen, K. S. Kaikkonen, M. J. Junttila, M. Isohanni, M.-L. Kortelainen & H. V. Huikuri. (2011) Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. European Heart Journal 33:6, pages 745-751.
Crossref
Crossref
. (2012) . Japanese Journal of Electrocardiology 32:1, pages 1-3.
Crossref
Crossref
Karl-Jürgen Bär & Heinrich Sauer. 2012. Positionen der Psychiatrie. Positionen der Psychiatrie
27
31
.
Li-Ren Chang, Yu-Hsuan Lin, Terry B. J. Kuo, Hung-Chieh Wu Chang, Chih-Min Liu, Chen-Chung Liu, Hai-Gwo Hwu & Cheryl C. H. Yang. (2011) Autonomic Modulation and Health-Related Quality of Life among Schizophrenic Patients Treated with Non-Intensive Case Management. PLoS ONE 6:11, pages e26378.
Crossref
Crossref
A. Carlo Altamura, Marta Serati, Alessandra Albano, Riccardo A. Paoli, Ira D. Glick & Bernardo Dell’Osso. (2011) An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses. European Archives of Psychiatry and Clinical Neuroscience 261:7, pages 489-508.
Crossref
Crossref
Maria Vares, Peter Saetre, Pontus Strålin, Sten Levander, Eva Lindström & Erik G. Jönsson. (2011) Concomitant medication of psychoses in a lifetime perspective. Human Psychopharmacology: Clinical and Experimental 26:4-5, pages 322-331.
Crossref
Crossref
Anna-Karoline Israel, Andrea Seeck, Michael Karl Boettger, Tobias Rachow, Sandy Berger, Andreas Voss & Karl-Jürgen Bär. (2011) Peripheral endothelial dysfunction in patients suffering from acute schizophrenia: A potential marker for cardiovascular morbidity?. Schizophrenia Research 128:1-3, pages 44-50.
Crossref
Crossref
Fulvio A. Scorza, Esper A. Cavalheiro, Marly de Albuquerque, Juliana de Albuquerque, Roberta M. Cysneiros, Vera C. Terra & Ricardo M. Arida. (2011) Thyroid gland and cerebella lesions: New risk factors for sudden cardiac death in schizophrenia?. Medical Hypotheses 76:2, pages 251-253.
Crossref
Crossref
Brian M. Ross, Sandeep Shah & Malcolm Peet. (2011) Increased breath ethane and pentane concentrations in currently unmedicated patients with schizophrenia. Open Journal of Psychiatry 01:01, pages 1-7.
Crossref
Crossref
Chin-Kuo Chang, Richard D Hayes, Matthew Broadbent, Andrea C Fernandes, William Lee, Matthew Hotopf & Robert Stewart. (2010) All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 10:1.
Crossref
Crossref
Jae Seung Chang, Cheol Sung Yoo, Sang Hoon Yi, Kye Hyun Hong, Yu-Sang Lee, Hong Seok Oh, Dong Chung Jung, Yong Sik Kim & Yong Min Ahn. (2010) Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:6, pages 924-929.
Crossref
Crossref
Hilario Blasco-Fontecilla, Enrique Baca-Garcia & Jose de Leon. (2010) Do atypical antipsychotic drugs reduce the risk of ischemic heart disease and mortality? Possible role of 5-HT2A receptor blockade. Schizophrenia Research 119:1-3, pages 160-163.
Crossref
Crossref
Pierre Landry, Anne‐Marie Rousseau & Leila Skalli. 2010. Clinical Trials in Psychopharmacology. Clinical Trials in Psychopharmacology
337
380
.
Ramón Ramos-Ríos, Manuel Arrojo-Romero, Eduardo Paz-Silva, Fernando Carballal-Calvo, José L. Bouzón-Barreiro, Jorge Seoane-Prado, Rosario Codesido-Barcala, Alicia Crespí-Armenteros, Ramón Fernández-Pérez, Javier D. López-Moríñigo, Ignacio Tortajada-Bonaselt, Francisco J. Diaz & Jose de Leon. (2010) QTc interval in a sample of long-term schizophrenia inpatients. Schizophrenia Research 116:1, pages 35-43.
Crossref
Crossref
Delmar D. Short, Joanne M. Hawley & Maureen F. McCarthy. (2009) Management of Schizophrenia with Medical Disorders: Cardiovascular, Pulmonary, and Gastrointestinal. Psychiatric Clinics of North America 32:4, pages 759-773.
Crossref
Crossref